Flibanserin is a serotonin 5-HT receptor agonist used as a sexual desire enhancer to treat hypoactive sexual desire disorder in premenopausal women. Originally researched as a potential antidepressant,… Read more
![Chemical structure of 1,1'-(Ethane-1,2-diyl)bis(1,3-dihydro-2H-benzo[d]imidazol-2-one)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F11-Ethane-12-diylbis13-dihydro-2H-benzodimidazol-2-one.png&w=3840&q=75)
![Chemical structure of 1,1'-(Piperazine-1,4-diylbis(ethane-2,1-diyl))bis(1,3-dihydro-2H-benzo[d]imidazol-2-one)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F11-Piperazine-14-diylbisethane-21-diylbis13-dihydro-2H-benzodimidazol-2-one.png&w=3840&q=75)
![Chemical structure of 1,3-bis(2-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2518011-18-0-13-bis2-4-3-Trifluoromethylphenylpiperazin-1-ylethyl-13-dihydro-2H-benzodimidazol-2-one.png&w=3840&q=75)
![Chemical structure of 1,3-Bis(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one Dihydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F13-Bis2-4-3-trifluoromethylphenylpiperazin-1-ylethyl-13-dihydro-2H-benzodimidazol-2-one-Dihydrochloride.png&w=3840&q=75)
![Chemical structure of 1,3-bis(2-Bromoethyl)-1H-benzo[d]imidazol-2(3H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2514955-87-2-13-bis2-Bromoethyl-1H-benzodimidazol-23H-one.png&w=3840&q=75)
![Chemical structure of 1,3-Dihydro-1-(1-methylethenyl)-3-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-2H-benzimidazol-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1971858-36-2-13-Dihydro-1-1-methylethenyl-3-2-4-3-trifluoromethylphenyl-1-piperazinylethyl-2H-benzimidazol-2-one.png&w=3840&q=75)
![Chemical structure of 1-(2-(4-(4-Hydroxy-3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F331763-97-4-1-2-4-4-Hydroxy-3-trifluoromethylphenylpiperazin-1-ylethyl-13-dihydro-2H-benzodimidazol-2-one.png&w=3840&q=75)
![Chemical structure of 1-(2-Bromoethyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F103784-03-8-1-2-Bromoethyl-13-dihydro-2H-benzodimidazol-2-one.png&w=3840&q=75)



![Chemical structure of 4-Methyl-1,3-dihydro-2H-benzo[b][1,4]diazepin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6276-48-8-4-Methyl-13-dihydro-2H-benzob14diazepin-2-one.png&w=3840&q=75)














![Chemical structure of Methyl 3-(4-(2-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)ethyl)piperazin-1-yl)benzoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FMethyl-3-4-2-2-oxo-23-dihydro-1H-benzodimidazol-1-ylethylpiperazin-1-ylbenzoate.png&w=3840&q=75)
![Chemical structure of Methyl 3-(4-(2-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)ethyl)piperazin-1-yl)benzoate Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FMethyl-3-4-2-2-oxo-23-dihydro-1H-benzodimidazol-1-ylethylpiperazin-1-ylbenzoate-Hydrochloride.png&w=3840&q=75)
Flibanserin is a serotonin 5-HT receptor agonist used as a sexual desire enhancer to treat hypoactive sexual desire disorder in premenopausal women. Originally researched as a potential antidepressant, the drug acts by modulating neurotransmitter levels to influence sexual interest and arousal. Pharmaceutical laboratories utilize this category of compounds, which includes Flibanserin reference standards, for rigorous analytical testing and quality control of the drug substance. This selection comprises necessary materials for impurity profiling, allowing for the identification and quantification of process-related impurities and degradation products that may arise during synthesis or storage. Additionally, scientists employ stable isotope labelled compounds as internal standards in mass spectrometry-based assays to ensure high precision and accuracy in pharmacokinetic studies and method validation, supporting the maintenance of stringent regulatory and safety standards throughout the drug development lifecycle.